Don’t just attend #ASH26, help shape it.

Apply to lead a 2026 Scientific Workshop and guide an interactive discussion on emerging data and scientific discoveries in a particular field of hematology. https://ow.ly/LHVI50YEwJ8

#Hematology #HemeOnc

Don’t miss your chance to contribute to the science at #ASH26. ASH is inviting member-led proposals for Scientific Symposia, Scientific Spotlights, and a Special Interest Session on Ancestry Origins in Personalized Medicine. 🔗 https://ow.ly/2yRR50Yyjwa

#HemeSky #MedSky

Applications are now open to lead a 2026 Scientific Workshop at #ASH26!

This is your opportunity to organize an interactive workshop highlighting recent data and scientific discoveries in a particular field of hematology.

Apply today: https://ow.ly/IlC350YwXBX

#HemeSky #HemeOnc #MedSky

#tandem26 #bmtsm Fleischhauer: thankfully, there is an ongoing German RCT comparing ATG and PTCy in >=7/8 MUD to give more definitive conclusion. Results planned at #ASH26.

Posttransplant cells for the win? DLI and adoptive cell therapy to eradicate MRD Abstract. Relapse remains the leading cause of failure after allogeneic stem cell transplantation (allo-SCT) for hematologic malignancies. Donor lymphocyte

It was a great pleasure sharing our thoughts on how to create more impact with DLIs …. It starts with registering what we do .. ashpublications.org/hematology/a... #ASH26 @ash.hematology.org

Thanks for all the great memories, my #ASH25 friends! Stay in touch, and looking forward to seeing your new abstracts at #ASH26. cc @ash.hematology.org